Search results for "epression"

showing 10 items of 1868 documents

Differential pathophysiological mechanisms of reduced P300 amplitude in schizophrenia and depression: a single trial analysis

1997

In order to address basic mechanisms behind a reduced averaged P300 wave in schizophrenia and depression, 17 unmedicated schizophrenic and 11 unmedicated depressive subjects were tested in an 'oddball paradigm' against healthy controls matched for gender and age. The amplitude distributions of single trials' maximum positive deflections after stimulation (P300) for both target and nontarget stimuli were determined, which served as a basis for calculating the discrimination index d'. This index characterizes differences in the electrophysiological responses to target and nontarget stimuli of a subject being engaged in a discrimination task. As a main result d' was significantly lower for sch…

AdultMalePsychosismedicine.medical_specialtyAudiologyDiscrimination LearningReference ValuesReaction TimemedicineHumansAttentionPsychiatryOddball paradigmBiological PsychiatryDepression (differential diagnoses)Cerebral CortexDepressive DisorderCognitive disorderMiddle Agedmedicine.diseaseEvent-Related Potentials P300PathophysiologyPsychiatry and Mental healthElectrophysiologySchizophreniaSchizophreniaFemaleSingle trialArousalPsychologySchizophrenia Research
researchProduct

Detection of Depression in Acute Schizophrenia: Sensitivity and Specificity of 2 Standard Observer Rating Scales

2006

Objective: To compare the psychometric properties of the Calgary Depression Rating Scale (CDRS) and the Hamilton Depression Rating Scale (HDRS) for severity assessment of depression in acute schizophrenia. Method: During clinical routine treatment, we investigated 119 inpatients with acute schizophrenia, using the CDRS, the HDRS, and a global 4-point Depression Severity Scale (DEP-SEV). We compared CDRS and HDRS sum scores regarding their diagnostic accuracy, with global severity of depression as the criterion. We estimated sensitivity and specificity on the basis of receiver operating characteristic curves. Results: According to global clinical ratings (DEP-SEV), 31% of patients had no dep…

AdultMalePsychosismedicine.medical_specialtyPsychometricsAcute schizophreniaStatistics as TopicComorbidityPersonality AssessmentSeverity assessmentRating scaleGermanymedicineHumansPsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive Disorder MajorReproducibility of Resultsmedicine.diseasePsychiatry and Mental healthROC CurveSchizophreniaAcute DiseaseSchizophreniaFemaleStandard observerPsychologyClinical psychologyThe Canadian Journal of Psychiatry
researchProduct

Benchmarking of cognitive-behavioral therapy for depression in efficacy and effectiveness studies--how do exclusion criteria affect treatment outcome?

2011

Abstract Objective: Little is known about how exclusion criteria applied in randomized controlled trials (RCTs) affect the transfer of psychotherapy outcome research to naturalistic settings. This study evaluated the effects of naturalistic depression therapies and benchmarked them with published RCTs. Method: Commonly used exclusion criteria were applied to n=338 depressive patients receiving cognitive-behavioral therapy. Outcomes of the resulting subsample eligible for RCTs were compared to those reported in RCTs. Results: Treatment outcomes of the total sample (d=1.16) and the subsample eligible for RCTs (d=1.15) were highly similar. Therapy outcome was worse than in high-quality RCTs (d…

AdultMalePsychotherapistmedicine.medical_treatmentTreatment outcomeAffect (psychology)law.inventionRandomized controlled triallawhealth services administrationmedicineHumansDepression (differential diagnoses)Randomized Controlled Trials as TopicTherapy OutcomeDepressive DisorderCognitive Behavioral TherapyPatient SelectionBenchmarkingCognitive behavioral therapyClinical PsychologyBenchmarkingTreatment OutcomeFemaleDysthymic DisorderPsychologyPsychotherapy research : journal of the Society for Psychotherapy Research
researchProduct

Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients

2008

Background Hereditary angioedema (HAE) due to C1 inhibitor deficiency is clinically characterized by relapsing skin swellings, abdominal pain attacks, and life-threatening upper airway obstruction. Treatment with androgens prevents attacks for those with this condition. Objective To examine the benefits and risks of long-term treatment with danazol. Methods Data were generated retrospectively from 118 German and Danish patients who had HAE due to C1 inhibitor deficiency and were treated with danazol from 2 months to 30 years. The frequency and severity of acute attacks were registered before and during danazol treatment, and adverse effects to the treatment were noted. Data were collected b…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAbdominal painPediatricsImmunologyDose-Response Relationship ImmunologicRisk AssessmentSeverity of Illness IndexEcallantideSeverity of illnessmedicineHumansImmunology and AllergyAdverse effectDepression (differential diagnoses)Retrospective StudiesDanazolbusiness.industryDanazolAngioedemas HereditaryEstrogen AntagonistsMiddle Agedmedicine.diseaseSurgeryDiscontinuationHereditary angioedemaFemalemedicine.symptombusinessFollow-Up Studiesmedicine.drugAnnals of Allergy, Asthma & Immunology
researchProduct

Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study

2019

Abstract Background Although many studies have highlighted the link between asthma/rhinitis and depression, it is still unclear which characteristics of these diseases are associated with the risk of depression. We aimed to explore the relationship between depression and asthma or rhinitis in a representative sample of the Italian general population. Methods The data were collected in GEIRD, an Italian multicenter, population-based, multicase-control study. 2227 participants (age 21–86 years, female 50%) underwent standardized interviews, skin prick and lung function tests, and were divided into cases of current asthma (n = 528), rhinitis without asthma (n = 972), and controls (n = 727). Tw…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyActivities of daily livingPopulationSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary function testingAtopyYoung Adult03 medical and health sciences0302 clinical medicineAsthma controlInternal medicinemedicineHumans030212 general & internal medicineMedical prescriptioneducationAgedRhinitisAsthmaAged 80 and overeducation.field_of_studyAtopyDepressionbusiness.industryAnhedoniaGeneral populationMiddle Agedmedicine.diseaseAsthmaPatient Health QuestionnaireItaly030228 respiratory systemAsthma control; Atopy; Depression; General population; Rhinitis controlRhinitis controlFemalemedicine.symptombusinessRespiratory Medicine
researchProduct

Gender Differences in Health‐Related Quality of Life Among Patients with Asthma

2004

This study has a twofold objective: 1) to explore to what extent suffering from asthma affects the HRQL of men and women differently at several stages of disease severity and 2) to analyze whether the informed poorer HRQL of asthmatic women is related to their higher scores on instruments measuring emotionally disordered symptoms. One hundred fifty-one outpatient asthmatics (84 women and 67 men) completed the Spanish versions of the Asthma Quality of Life questionnaire (AQL), as well as anxiety and depression inventories. A full history, physical examination, and pulmonary function test were performed on all subjects. Patients were classified into one of four asthma severity categories foll…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentPhysical examinationmacromolecular substancesSeverity of Illness IndexPulmonary function testingSex FactorsQuality of lifeSeverity of illnessmedicineHumansImmunology and AllergyDepression (differential diagnoses)AsthmaDepressive Disordermedicine.diagnostic_testbusiness.industryRespiratory diseaseMiddle Agedmedicine.diseaseAnxiety DisordersAsthmarespiratory tract diseasesDyspneaPediatrics Perinatology and Child HealthQuality of LifePhysical therapyAnxietyFemalemedicine.symptombusinessClinical psychologyJournal of Asthma
researchProduct

Automated Determination of Fluvoxamine in Plasma by Column-Switching High-Performance Liquid Chromatography

1992

Abstract A column-switching system with high-performance liquid-chromatographic separation and ultraviolet detection is described for automated determination of fluvoxamine in human plasma or serum. Samples were injected and the drug was retained in a clean-up column [20 x 4.6 mm (i.d.)] filled with C8 reversed-phase material (10-micron particles). After unwanted material was washed out, the drug was eluted and separated with an analytical chromatography column, 4.6 x 250 mm (i.d.), filled with Nucleosil 100 CN (5-micron particles) with an acetonitrile:methanol:0.01 mol/L phosphate buffer eluent (188:578:235 by vol) at a flow rate of 1.5 mL/min for < 20 min and detected by spectromet…

AdultMaleQuality ControlDetection limitAutoanalysisChromatographyDepressionChemistryElutionBiochemistry (medical)Clinical BiochemistryFluvoxamineMiddle AgedMass spectrometryHigh-performance liquid chromatographyColumn chromatographyFluvoxaminemedicineHumansFemaleChromatography columnQuantitative analysis (chemistry)Chromatography High Pressure LiquidAgedmedicine.drugClinical Chemistry
researchProduct

Relationship between device acceptance and patient-reported outcomes in Left Ventricular Assist Device (LVAD) recipients

2019

AbstractThe number of Left Ventricular Assist Devices (LVADs) implanted each year is rising. Nevertheless, there are minimal data on device acceptance after LVAD implant, and on its relationship with patient-reported outcomes. We designed a cross-sectional study to address this knowledge gap and test the hypothesis that low device acceptance is associated with poorer quality of life, depression and anxiety. Self-report questionnaires were administered to assess quality of life (12-item Kansas City Cardiomyopathy Questionnaire quality of life subscale), level of anxiety (7-item Generalized Anxiety Disorder; GAD-7), level of depression (9-item Patient Health Questionnaire; PHQ-9) and device a…

AdultMaleQuality of life0301 basic medicinemedicine.medical_specialtyGeneralized anxiety disorderdevice acceptance.body imagemedicine.medical_treatmentPsychological interventionlcsh:MedicineHeart failureArticle03 medical and health sciences0302 clinical medicineQuality of lifemedicineHumansPatient Reported Outcome Measureslcsh:ScienceDepression (differential diagnoses)AgedCardiac device therapyAged 80 and overMultidisciplinarybusiness.industrylcsh:RMiddle Agedmedicine.diseaseLeft Ventricular Assist Deviceanxiety3. Good healthPatient Health QuestionnaireDistress030104 developmental biologyOutcomes researchVentricular assist devicedepressionPhysical therapyAnxietyFemalelcsh:QHeart-Assist Devicesmedicine.symptombusiness030217 neurology & neurosurgeryScientific Reports
researchProduct

Quality of life, depression and fatigue in mildly disabled patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon bet…

2011

Background: The precise relationships among quality of life, depression, fatigue and cognitive impairment in multiple sclerosis (MS) are complex and poorly understood. Objective: To assess the effects of subcutaneous interferon beta-1a on quality of life, depression and fatigue over 3 years in the COGIMUS study, and to examine the relationship between these outcomes and baseline cognitive status. Methods: COGIMUS was an observational 3-year trial assessing cognitive function in 459 patients with relapsing–remitting MS treated with subcutaneous interferon beta-1a. Results: In total, 331 patients completed the study (168 received interferon beta-1a, 44 µg subcutaneously three times weekly, a…

AdultMaleQuality of lifeLongitudinal studymedicine.medical_specialtyInjections Subcutaneousmultiple sclerosisRelapsing-Remitting Multiple SclerosisInterferon beta 1aYoung AdultMultiple Sclerosis Relapsing-RemittingAdjuvants ImmunologicQuality of lifeInternal medicinemedicineHumansYoung adultFatigueDepression (differential diagnoses)AgedDepressionbusiness.industryCognitive function; Depression; Fatigue; Interferon beta 1a; Longitudinal study; Quality of life; Relapsing-Remitting Multiple SclerosisMultiple sclerosisCognitive disorderInterferon beta-1aInterferon-betaMiddle Agedmedicine.diseaseClinical trialNeurologyPhysical therapymultiple sclerosis cognition interferon betaFemaleSettore MED/26 - NeurologiaCognitive functionNeurology (clinical)Longitudinal studyCognition DisordersbusinessInterferon beta-1amedicine.drugMultiple Sclerosis Journal
researchProduct

Depression and religiosity in older age

2011

Abstract We investigated the hypothesis that religious commitment could help counter general affective distress, accompanying depressive symptoms, in older age. A total of 34 older adults, all catholic believers, completed self-reported questionnaires on the presence of depressive symptoms, religiosity, health, worry, and the style of coping with stress. The depressive and non-depressive subgroups were then created. The prevalence of depressive symptoms was 50%, with the substantial predominance of females. Regression analyses indicate that health expectations and worry significantly worsen with increasing intensity of depressive symptoms. The results further show that religious engagement …

AdultMaleReligious commitmentAgingCoping (psychology)medicine.medical_specialtymedia_common.quotation_subjectAffective distresslcsh:MedicineReligiosityAgemedicineHumanspsychosomatic healthPsychiatryDepressive symptomsAgedmedia_commonAged 80 and overResearchReligion and Medicinelcsh:RGeneral MedicineMiddle AgedPrognosisreligiosityDistressMedicine public healthdepressionFemaleWorryPsychologyEuropean Journal of Medical Research
researchProduct